Operating
Change in AR
AbbVie Change in AR decreased by 155.8% to -$87.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 105.9%, from $1.48B to -$87.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026May 8, 2026
How to read this metric
A decrease is generally positive as it indicates faster collection of cash from customers.
Detailed definition
This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...
Peer comparison
Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.
Metric ID:
change_in_accounts_receivableHistorical Data
15 periods
| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $296.00M | $749.00M | $785.00M | $611.00M | $416.00M | $195.00M | $80.00M | -$2.00M | -$339.00M | $702.00M | -$387.00M | $1.48B | $17.00M | $156.00M | -$87.00M |
| QoQ Change | — | +153.0% | +4.8% | -22.2% | -31.9% | -53.1% | -59.0% | -102.5% | <-999% | +307.1% | -155.1% | +482.2% | -98.9% | +817.6% | -155.8% |
| YoY Change | — | — | — | +106.4% | -44.5% | -75.2% | -86.9% | — | -181.5% | +260.0% | -14.2% | +110.7% | — | — | -105.9% |
Range-$387.00M – $1.48B
CAGR-29.5%
Avg YoY Growth-3.4%
Median YoY Growth-44.5%
Change in AR at Other Companies
Frequently Asked Questions
- What is AbbVie's change in ar?
- AbbVie (ABBV) reported change in ar of -$87.00M in Q1 2026.
- How has AbbVie's change in ar changed year-over-year?
- AbbVie's change in ar decreased by 105.9% year-over-year, from $1.48B to -$87.00M.
- What does change in ar mean?
- The change in money owed to the company by customers for past sales.